Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
oleh: Koichiro Yamamoto, Kaoru Nakamura, Hideharu Hagiya, Fumio Otsuka
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2021-09-01 |
Deskripsi
Abstract COVID‐19 patients treated with anti‐inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID‐19 treatment.